Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Oncoimmunology|June 22, 2012
Infiltrating CTLs are bothered by HLA-E on tumorsMarloes J M Gooden, Thorbald van HallCurrent Opinion in Immunology|February 8, 2011
Strategies to counteract MHC-I defects in tumorsMargit H Lampen, Thorbald van HallFrontiers in Immunology|June 23, 2015
Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to RomeCláudia C Oliveira, Thorbald van HallCurrent Opinion in Immunology|January 18, 2020
To TAP or not to TAP: alternative peptides for immunotherapy of cancerKoen A Marijt, Thorbald van HallMolecular Immunology|November 28, 2012
Importance of TAP-independent processing pathwaysClaudia C Oliveira, Thorbald van HallInternational Journal of Molecular Sciences|September 10, 2021
Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the SpotlightsMarieke F Fransen, Thorbald van Hall, Ferry OssendorpAdvances in Immunology|March 28, 2012
Mechanisms of peptide vaccination in mouse models: tolerance, immunity, and hyperreactivityThorbald van Hall, Sjoerd H van der BurgMolecular Immunology|April 9, 2018
TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class I<sup>low</sup> cancersKoen A Marijt, Elien M Doorduijn, Thorbald van HallClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
The NKG2A-HLA-E Axis as a Novel Checkpoint in the Tumor MicroenvironmentLinda Borst, Sjoerd H van der Burg, Thorbald van HallOncoimmunology|August 17, 2017
PD-L1 immune suppression in cancer: Tumor cells or host cells?Jan Willem Kleinovink, Thorbald van Hall, Ferry Ossendorp, et al.Pageof 13